Half Year Investor Conference 2002

August 1, 2002, London

Investor News August 1, 2002
Werner Wenning on Bayer’s first-half results:
“2002 is a year of transition in which we are creating the basis for future growth”
Sales and operating result depressed by continuing economic weakness and pharmaceutical product withdrawal / Divestment proceeds should mean higher net income for the full year
Download PDF collect (582 KB)

The audio recording of this event is no longer available

Recent development and First Half 2002 results
Werner Wenning,
CEO of Bayer AG
Download PDF collect (379 KB)